Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Cerebrovascular Accident / Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01938248Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation